TUTONE, Marco
TUTONE, Marco
Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
3D-QSAR Pharmacophore Modeling and in Silico Screening of new Bcl-xl Inhibitors
2010-01-01 Almerico, AM; Tutone, M; Lauria, A
A definitive pharmacophore modelling study on CDK2 ATP pocket binders: Tracing the path of new virtual high-throughput screenings
2020-01-01 Tutone M.; Culletta G.; Livecchi L.; Almerico A.M.
A dynamic multiple receptor conformations (MD-MRC) approach to enhance early enrichment in virtual screening. A case study on PPAR-alpha
2016-01-01 Perricone, U; Wieder, M; Seidel, T; Langer, T; Almerico, AM; Tutone, M.
A dynamic-common pharmacophore approach to improve virtual screening. A case study on PPAR-alpha
2016-01-01 Perricone, U; Almerico, AM; Tutone, M.
A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α
2017-01-01 Perricone, U.; Wieder, M.; Seidel, T.; Langer, T.; Padova, A.; Almerico, A.; Tutone, M.
A Multivariate Analysis of HIV-1 Protease Inhibitors and Resistance Induced by Mutation
2006-01-01 ALMERICO, AM; TUTONE, M; LAURIA, A; DIANA, P; BARRAJA, P; MONTALBANO, A; CIRRINCIONE, G; DATTOLO, G
A multivariate analysis on HIV-1 protease inhibitors and resistance induced by mutation
2006-01-01 ALMERICO AM; LAURIA A; TUTONE M; DIANA P; BARRAJA P; MONTALBANO A; CIRRINCIONE G; DATTOLO G
A multivariate analysis on non-nucleoside HIV-1 reverse transcriptase inhibitors and resistance induced by mutation
2004-01-01 7ALMERICO, AM; LAURIA, A; TUTONE, M; BARRAJA, P; MONTALBANO, A; CIRRINCIONE, G; DATTOLO, G
A QSAR study investigating the potential anti-HIV-1 effect of some Acyclovir and Ganciclovir analogs
2009-01-01 Almerico, AM; Tutone, M; Lauria, A
A3 Adenosine Receptor: homology modeling and 3D-QSAR studies
2011-01-01 ALMERICO, AM; TUTONE, M; PANTANO, L; LAURIA, A
A3 adenosine receptor: Homology modeling and 3D-QSAR studies
2013-01-01 Almerico, AM; Tutone, M; Pantano, L; Lauria, A
ADME, Toxicity, Molecular Docking, Molecular Dynamics, Glucokinase activation, DPP‐IV, α‐amylase, and α‐glucosidase Inhibition Assays of Mangiferin and Friedelin for Antidiabetic Potential
2025-01-19 Suryawanshi, Ravikiran Maheshrao; Shimpi, Rupali Bhalchandra; Muralidharan, V.; Nemade, Lalita Shashikant; Gurugubelli, Simhachalam; Baig, Shahajan; Vikhe, Sunayana Rahul; Dhawale, Sachin A.; Mortuza, Mohammad Rakib; Sweilam, Sherouk Hussein; Siddiqui, Falak A.; Khan, Sharuk L.; Tutone, Marco; Ahmad, Irfan; Begh, Md. Zamshed Alam
Aminoquinolines: Fluorescent sensors to DNA – A minor groove probe. Experimental and in silico studies
2023-10-01 de Carvalho Bertozo L.; Tutone M.; Pastrello B.; da Silva-Filho L.C.; Culletta G.; Almerico A.M.; Farias Ximenes V.
Analisi Multivariata e Docking nello Studio degli Inibitori di HIV-1 Integrasi
2005-01-01 TUTONE M; LAURIA A; ALMERICO AM
Bcl-2 come target di farmaci antitumorali modulatori dell'apoptosi
2007-01-01 TUTONE M; LAURIA A; ALMERICO AM
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis
2024-08-28 Scalia F.; Culletta G.; Barreca M.; Caruso Bavisotto C.; Bivacqua R.; D'Amico G.; Alberti G.; Spano' V.; Tutone M.; Almerico A.M.; Cappello F.; Montalbano A.; Barraja P.
Clinical missense mutations in MMACHC gene affect its conformational stability and vitamin B12-binding activity: The example of R161Q mutation.
2024-09-01 Vilasi S.;Longo L.; Randazzo L.; Bollati M.; Velazquez Campoy A.; Carrotta R.; Costa M.A.; De Rosa M.; Ortore M.G.; Mangione M.R.; Martorana V.; Milani M.; Tutone M.; Passantino R
Comparing molecular dynamics-derived pharmacophore models with docking: A study on CDK-2 inhibitors
2020-01-01 Culletta G.; Almerico A.M.; Tutone M.
Computational Approaches and Drug Discovery: Where Are We Going?
2024-02-22 Tutone, Marco; Almerico, Anna Maria